Search

Your search keyword '"Tomazic, P. V."' showing total 218 results

Search Constraints

Start Over You searched for: Author "Tomazic, P. V." Remove constraint Author: "Tomazic, P. V."
218 results on '"Tomazic, P. V."'

Search Results

2. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study

4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

5. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

6. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

9. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

11. The ARIA-MeDALL hypothesis

13. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

14. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

15. Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome

16. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

17. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

18. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers

19. Work productivity in rhinitis using cell phones: The MASK pilot study

20. Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

21. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

22. T2-Inflammation bei entzündlichen Atemwegserkrankungen: Grundlage neuer Behandlungsoptionen

23. Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper

24. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

27. Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie : Ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion)

28. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

29. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

30. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic [Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie]

31. Treatment of allergic rhinitis during and outside the pollen season using mobile technology : A MASK study

32. Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing

33. Allergen immuntherapy in the current COVID-19 pandemic - A position paper of ARIA, EAACI, AeDA, DGAKI, and GPA

34. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID 19 pandemic

35. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA- EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)

36. European Position Paper on Rhinosinusitis and Nasal Polyps 2020

39. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis

40. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

41. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

42. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

43. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

44. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

45. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

46. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

47. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

49. Daily allergic multimorbidity in rhinitis using mobile technology : A novel concept of the MASK study

50. Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire using Mobile Technology: The MASK study.

Catalog

Books, media, physical & digital resources